Historical perspectives in oncology
From shadows to light — how cancer care evolved. Telegraphic; sources linked where available.
Subtopics
Halsted and Beatson: surgery and hormones · From shadows to light: X-rays, radium and radiotherapy · The Radium Girls · Nitrogen mustard and Farber’s antifolates · Cisplatin and testicular cancer · Trastuzumab: targeted therapy arrives · Imatinib for CML · HPV vaccine · Ipilimumab: checkpoint era · Tissue-agnostic: MSI-H/dMMR · ADCs, organ preservation, ctDNA
1890s — Halsted and Beatson: surgery and hormones
Radical mastectomy set the surgical template; Beatson’s oophorectomy showed breast cancer could respond to hormone removal — the first systemic idea.
1896–1900s — From shadows to light: X-rays, radium and radiotherapy
Röntgen’s X-rays (1895) and the Curies’ radium (1898) birthed radiotherapy within years. Source
1917–1930s — The Radium Girls
Dial painters who lip-pointed radium brushes developed jaw necrosis and cancers; their lawsuits shaped occupational-safety law. Source
1940s — Nitrogen mustard and Farber’s antifolates
Mustard derivatives and Farber’s aminopterin remissions in childhood leukaemia opened the chemotherapy era.
1978 — Cisplatin and testicular cancer
Cisplatin turned metastatic testicular cancer into a largely curable disease.
1998 — Trastuzumab: targeted therapy arrives
HER2 antibody plus chemotherapy improved survival in HER2+ metastatic breast cancer (Slamon, NEJM 2001). Source
2001 — Imatinib for CML
A pill targeting BCR-ABL — the proof-of-concept for driver-targeted therapy (Druker, NEJM 2001). Source
2006 — HPV vaccine
First vaccine aimed at preventing a cancer; central to India’s cervical-cancer elimination plans.
2011 — Ipilimumab: checkpoint era
First checkpoint inhibitor to improve survival in melanoma (NEJM 2011). Source
2017 — Tissue-agnostic: MSI-H/dMMR
Pembrolizumab approved by biomarker, not organ — rooted in Le et al., NEJM 2015. Source
2020s — ADCs, organ preservation, ctDNA
T-DXd, dostarlimab organ-sparing in dMMR rectal cancer, ctDNA-guided care. Source
India note
Cancer history in India runs through Tata Memorial (1941) and the Adyar Cancer Institute, Chennai (1954) — affordable, evidence-led care remains the thread.
More: Best of cancer media · Gallery